How safety features make or break infusion pump design
In this article, Charlotte Harvey, Medical Sector Manager, and Tim Frearson, Senior Consultant, both of Sagentia...
The future of cosmetics and beauty: now it’s personal
Innovation in the cosmetics and beauty industry has traditionally been dominated by R&D advancements in formulation...
Next-gen medical devices demand new breed of architect
As the technical lead in medical device development, software architects have a challenging role to fulfil. This is...
Medical devices: the shift from embedded to connected
Five principles to help software architects walk the line between opportunity and threat. Software architects in the...
Precision delivery: a chance for a fresh perspective
Precision delivery of agricultural chemicals — whether they be pesticide, herbicide or fertiliser — will be the big...
Breaking up with plastic: the direct-to-consumer opportunity
By Simon Norman, Applied Science Consultant at Sagentia In our recent white paper ‘Breaking up with plastic’...
Quality control testing in CAR-T cell manufacture
Sagentia recently sponsored the Cell and Gene Therapy Strategy Meeting, held in Boston on 12th June 2018. Rob Morgan...
Corporate attitudes to technology and product roadmapping
If you would like to understand more about our roadmapping services, email Download the slide deck here Download...
Assessing the options for companies setting challenging goals for plastic reduction
In a move to help tackle the problems of plastic reduction, many companies have set themselves ambitious goals for the...
Conventional plastics and bioplastics: How can we move from the former to the latter
Plastic products are ubiquitous due to their particular material properties – properties that scientists and...
